| |
 |
|
Class Information
Number: 424/252.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Brucella (e.g., brucella abortus, brucella canis, etc.)
Description: Subject matter wherein the bacterium is of the genus Brucella.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7384640 |
Mutant cholera holotoxin as an adjuvant |
Jun. 10, 2008 |
| 7364745 |
Development of a live, attenuated, recombinant vaccine for Brucellosis |
Apr. 29, 2008 |
| 7118739 |
Biocontrol of plant diseases caused by Fusarium species with novel isolates of Pantoea agglomerans |
Oct. 10, 2006 |
| 7041296 |
Methods of treating inflammatory bowel disease using cholera toxin B subunit |
May. 9, 2006 |
| 6991793 |
Method of protecting fish against columnaris disease with modified live Flavobacterium columnare |
Jan. 31, 2006 |
| 6811787 |
Over-expressing homologous antigen vaccine and a method of making the same |
Nov. 2, 2004 |
| 6605696 |
Lawsonia intracellularis proteins, and related methods and materials |
Aug. 12, 2003 |
| 6599509 |
Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
Jul. 29, 2003 |
| 6582699 |
Combination vaccine for enhancing immunity against brucellosis |
Jun. 24, 2003 |
| 6444210 |
Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity |
Sep. 3, 2002 |
| 6444445 |
Live vaccine against Brucellosis |
Sep. 3, 2002 |
| 6436652 |
Method of detecting a pathogen using a virus |
Aug. 20, 2002 |
| 6296855 |
17-KDA Brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
Oct. 2, 2001 |
| 6277379 |
Use of purified invaplex from gram negative bacteria as a vaccine |
Aug. 21, 2001 |
| 6221386 |
Use of virulence factors of pathogens to improve liposomal delivery of therapeutic agents |
Apr. 24, 2001 |
| 6203799 |
Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit |
Mar. 20, 2001 |
| 6149920 |
Over-expressing homologous antigen vaccine and a method of making the same |
Nov. 21, 2000 |
| 5997881 |
Method of making non-pyrogenic lipopolysaccharide or A |
Dec. 7, 1999 |
| 5951987 |
Polysaccharide vaccine to enhance immunity against brucellosis |
Sep. 14, 1999 |
| 5939075 |
Mutants of Brucella melitensis |
Aug. 17, 1999 |
| 5906826 |
Method of inducing an immune response in a young animal |
May. 25, 1999 |
| 5858352 |
Vaccine containing a Shigella bacterium having an enhanced antigenic property |
Jan. 12, 1999 |
| 5855894 |
Pasteurella haemolytica type A-1 bacterin-toxoid vaccine |
Jan. 5, 1999 |
| 5804199 |
Oil-based and water-based adjuvant mixture |
Sep. 8, 1998 |
| 5718903 |
Vaccine comprising Brucella abortus which has O polysaccharide antigen absent |
Feb. 17, 1998 |
| 5006463 |
Immunoassays for discriminating between brucellosis infections and vaccinations |
Apr. 9, 1991 |
| 4764370 |
Vaccine utilizing an avirulent strain of Salmonella typhimurium |
Aug. 16, 1988 |
| 4701323 |
Vaccines for counteracting inhibition of neutrophil degranulation |
Oct. 20, 1987 |
| 4493825 |
Purified and antigenically selective vaccines for domestic animals |
Jan. 15, 1985 |
| 4340588 |
Brucellosis vaccine for cattle containing mycolate esters of trehalose |
Jul. 20, 1982 |
| 4152412 |
Marking vaccine |
May. 1, 1979 |
|
|
|
